Genetron Health to Present at Upcoming Investor Conferences

Rhea-AI Summary

Genetron Holdings Limited (Nasdaq: GTH), a precision oncology leader in China, announced participation in three investor conferences in April and May 2021. The management will present at the UBS Virtual Healthcare Summit on April 28-29, followed by the Soochow Securities Innovative Medical Device Corporate Summit in Shanghai on April 30, where Chief Medical Officer Dr. Yun-Fu Hu will speak. The third event is the CICC Healthcare Industry Forum from May 18-19, with CEO Sizhen Wang presenting. Further details are available through their sales representatives.

BEIJING, April 22, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that management will present and host one-on-one meetings at three upcoming investor conferences.

Details related to the management team’s participation are as follows:

Conference: UBS Virtual Healthcare Summit
Location: Virtual
Dates: April 28-29, 2021

Conference: Soochow Securities, “Innovative Medical Device Corporate Summit”
Location: Shanghai
Dates: April 30, 2021
Presentation: Chief Medical Officer, Dr. Yun-Fu Hu will present on April 30, 2021

Conference: CICC Healthcare Industry Forum 2021, “Innovation Drives Growth, Quality Drives Consumption”
Location: Shanghai
Dates: May 18-19, 2021
Presentation: Co-Founder and CEO, Sizhen Wang will present on May 18, 2021

Interested parties may request more information by contacting their sales representatives at UBS, Soochow Securities, and CICC.

About Genetron Holdings Limited

Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq:GTH) is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive oncology portfolio that covers the entire spectrum of cancer management, addressing needs and challenges from early screening, diagnosis and treatment recommendations, as well as continuous disease monitoring and care. Genetron Health also partners with global biopharmaceutical companies and offers customized services and products. For more information, please visit ir.genetronhealth.com.

Safe Harbor Statement

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as “may”, “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.

Investor Relations Contact
US:
Hoki Luk
Head of Investor Relations
Email: hluk@genetronhealth.us
Phone: +1 (408) 891-9255

David Deuchler, CFA
Managing Director | Gilmartin Group
Email: ir@genetronhealth.com

 

FAQ

What is the date of Genetron Holdings' participation in the UBS Virtual Healthcare Summit?

Genetron Holdings will participate in the UBS Virtual Healthcare Summit on April 28-29, 2021.

Who will present at the Soochow Securities summit for Genetron Holdings?

Chief Medical Officer Dr. Yun-Fu Hu will present at the Soochow Securities summit on April 30, 2021.

When is the CICC Healthcare Industry Forum scheduled for Genetron Holdings?

The CICC Healthcare Industry Forum is scheduled for May 18-19, 2021.

What is the purpose of Genetron Holdings' investor conference participation?

Genetron Holdings aims to share insights on their precision oncology platform, molecular profiling tests, and cancer management solutions.

What stock symbol is associated with Genetron Holdings?

Genetron Holdings is listed under the stock symbol GTH.